Efficacy and safety of apremilast in patients with mild-to-moderate psoriasis up to 32 weeks: Results from the extension phase of the randomized, phase 3 ADVANCE trial

Autor:	Linda Stein Gold, Kim Papp, David Pariser, Neal Bhatia, Howard Sofen, Lorne Albrecht, Melinda Gooderham, Kristina Callis Duffin, Mindy Chen, Maria Paris, Sue Cheng, Hernan Picard, Yao Wang, Lawrence Green
Rok vydání:	2023
Předmět:	Dermatology
Zdroj:	Journal of the American Academy of Dermatology. 88:430-433
ISSN:	0190-9622
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7775470878951da589a9f98073bf6ea4 https://doi.org/10.1016/j.jaad.2022.10.041 Zobrazit plný text záznamu Full Text from ScienceDirect